Literature DB >> 31187128

DASH Diet and Blood Pressure Among Black Americans With and Without CKD: The Jackson Heart Study.

Crystal C Tyson1, Clemontina A Davenport2, Pao-Hwa Lin1, Julia J Scialla1,3, Rasheeda Hall1, Clarissa J Diamantidis1, Joseph Lunyera1, Nrupen Bhavsar1, Casey M Rebholz4, Jane Pendergast2, L Ebony Boulware1, Laura P Svetkey1.   

Abstract

BACKGROUND: The Dietary Approaches to Stop Hypertension (DASH) diet lowers blood pressure (BP) more effectively in blacks compared to other US racial subgroups. Considering chronic kidney disease (CKD) raises BP through complex mechanisms, DASH may affect BP differently among blacks with and without CKD. We compared the association of DASH accordance to BP and prevalent hypertension among blacks with and without CKD.
METHODS: Our study involved 3,135 black Americans enrolled in the Jackson Heart Study (2000-2004) with diet and office BP data. Using linear models adjusted for demographics, health behaviors, and clinical factors, we determined the association of a modified DASH score (excluding sodium intake, ranging from 0 to 8 with increasing DASH accordance) with BP. We performed tests for interaction between DASH score and CKD status.
RESULTS: Among participants (mean age: 55 years; hypertension: 60%; CKD: 19%), the median DASH score was similar among participants with and without CKD (1.0 [interquartile range (IQR): 0.5-2] and 1.0 [IQR: 0.5-1.5]). CKD status modified the association of the DASH score with systolic BP (SBP) and diastolic BP (DBP; P interactions were 0.06 and <0.01). Among participants without CKD, SBP and DBP were not associated with the DASH score (-0.4 [95% confidence interval: -1.0, 0.1] mm Hg and -0.1 [-0.4, 0.2] mm Hg per one unit higher DASH score). Among participants with CKD, one unit higher DASH score was associated with lower SBP by 1.6 (0.5, 2.6) mm Hg and lower DBP by 0.9 (0.3, 1.5) mm Hg.
CONCLUSIONS: Despite low DASH scores overall, better DASH accordance was associated with lower BP among Black Americans with CKD. © American Journal of Hypertension, Ltd 2019. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Black American; blood pressure; chronic kidney disease; diet; hypertension; nutrition

Mesh:

Year:  2019        PMID: 31187128      PMCID: PMC6758942          DOI: 10.1093/ajh/hpz090

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   3.080


  38 in total

1.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

2.  2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Robert H Eckel; John M Jakicic; Jamy D Ard; Janet M de Jesus; Nancy Houston Miller; Van S Hubbard; I-Min Lee; Alice H Lichtenstein; Catherine M Loria; Barbara E Millen; Cathy A Nonas; Frank M Sacks; Sidney C Smith; Laura P Svetkey; Thomas A Wadden; Susan Z Yanovski; Karima A Kendall; Laura C Morgan; Michael G Trisolini; George Velasco; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

3.  Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults.

Authors:  Alexander A Leung; Stella S Daskalopoulou; Kaberi Dasgupta; Kerry McBrien; Sonia Butalia; Kelly B Zarnke; Kara Nerenberg; Kevin C Harris; Meranda Nakhla; Lyne Cloutier; Mark Gelfer; Maxime Lamarre-Cliche; Alain Milot; Peter Bolli; Guy Tremblay; Donna McLean; Karen C Tran; Sheldon W Tobe; Marcel Ruzicka; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Steven E Gryn; Ross D Feldman; Peter Selby; Andrew Pipe; Ernesto L Schiffrin; Philip A McFarlane; Paul Oh; Robert A Hegele; Milan Khara; Thomas W Wilson; S Brian Penner; Ellen Burgess; Praveena Sivapalan; Robert J Herman; Simon L Bacon; Simon W Rabkin; Richard E Gilbert; Tavis S Campbell; Steven Grover; George Honos; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Norman R C Campbell; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Ally Prebtani; Gregory Kline; Lawrence A Leiter; Charlotte Jones; Anne-Marie Côté; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Ross T Tsuyuki; Swapnil Hiremath; Denis Drouin; Kim L Lavoie; Pavel Hamet; Jean C Grégoire; Richard Lewanczuk; George K Dresser; Mukul Sharma; Debra Reid; Scott A Lear; Gregory Moullec; Milan Gupta; Laura A Magee; Alexander G Logan; Janis Dionne; Anne Fournier; Geneviève Benoit; Janusz Feber; Luc Poirier; Raj S Padwal; Doreen M Rabi
Journal:  Can J Cardiol       Date:  2017-03-10       Impact factor: 5.223

4.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

5.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

6.  Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.

Authors:  L P Svetkey; T J Moore; D G Simons-Morton; L J Appel; G A Bray; F M Sacks; J D Ard; R M Mortensen; S R Mitchell; P R Conlin; M Kesari
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

7.  Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial.

Authors:  L P Svetkey; D Simons-Morton; W M Vollmer; L J Appel; P R Conlin; D H Ryan; J Ard; B M Kennedy
Journal:  Arch Intern Med       Date:  1999-02-08

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.

Authors:  Nimrit Goraya; Jan Simoni; Chan-Hee Jo; Donald E Wesson
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

10.  DASH (Dietary Approaches to Stop Hypertension) Diet and Risk of Subsequent Kidney Disease.

Authors:  Casey M Rebholz; Deidra C Crews; Morgan E Grams; Lyn M Steffen; Andrew S Levey; Edgar R Miller; Lawrence J Appel; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2016-08-09       Impact factor: 8.860

View more
  2 in total

Review 1.  Etiopathogenesis of kidney disease in minority populations and an updated special focus on treatment in diabetes and hypertension.

Authors:  Ebele M Umeukeje; Jasmine T Washington; Susanne B Nicholas
Journal:  J Natl Med Assoc       Date:  2022-05-17       Impact factor: 2.739

2.  Plant-based diets and incident cardiovascular disease and all-cause mortality in African Americans: A cohort study.

Authors:  Leah J Weston; Hyunju Kim; Sameera A Talegawkar; Katherine L Tucker; Adolfo Correa; Casey M Rebholz
Journal:  PLoS Med       Date:  2022-01-05       Impact factor: 11.069

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.